🇺🇸 FDA
Patent

US 10844357

Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

granted A61KA61K2039/5254A61K2039/5258

Quick answer

US patent 10844357 (Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines) held by The Board of Regents for Oklahoma State University expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents for Oklahoma State University
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/5254, A61K2039/5258